Prostate Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have a prostate and are 18 years of age or older.
- People who have been diagnosed with prostate cancer through a biopsy and are scheduled to have their prostate surgically removed.
- People who have read and signed a consent form showing they understand what the study involves and why it is being done.
- People who are willing, able, and legally permitted to take part in the study.
- People who are able to follow the specific rules and restrictions set out in the study plan.
Who may not be able to join:
- People who are not able to give consent to participate.
- People who have previously received hormone treatments for prostate cancer, such as androgen deprivation therapy or 5-alpha-reductase inhibitors.
- People who have previously received any treatment for prostate cancer.
- People who have previously had a surgical procedure on the prostate, including a transurethral resection of the prostate (a procedure to remove prostate tissue through the urethra).
- People who have previously had hip replacement surgery on one or both sides, or who have other metal implants in the hip area that would interfere with MRI scanning.
- People who cannot have an MRI scan for general medical reasons, such as having a pacemaker or certain metal implants in the body.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Marcelo Araujo Queiroz, MD PhD, Instituto do Câncer do Estado de São Paulo
Phone: +4917680891277
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Comparison of different microstructure models in the performance of detecting csPCa
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.